Effective Antibody Treatments for COVID-19 Could Be Ready Soon
Regeneron Pharmaceuticals (NASDAQ: REGN) and Eli Lilly (NYSE: LLY) are both developing potential new coronavirus treatments that could become available long before any vaccine candidates have a chance to prove themselves safe and effective. In fact, at least one COVID-19 treatment candidate could become available in U.S. hospitals in time to make this Halloween a lot less frightening.
Image source: Getty Images.
Are these coronavirus treatment candidates worth the attention they're attracting right now? Here's what you should know about potential treatment options and the paths they're taking to reach patients that need them.
Source Fool.com
